Can a Daily Inhaler Revolutionize Lung Health? Climatic Launches L Max

NEW YORK, NY – April 21, 2026 – In a world where we track our steps, sleep, and hydration, health-tech company Climatic is betting that the next frontier in daily wellness is our lungs. The company today launched L Max, a product it bills as the world’s first breathable daily lung health system, aiming to transform reactive respiratory care into a proactive daily habit, much like brushing your teeth.

Delivered via a sleek, handheld inhaler in under 30 seconds, L Max is designed to cleanse and clear the airways. The launch positions Climatic at the forefront of a potential new category, challenging consumers to consider the 20,000 breaths they take each day as a core pillar of their health and performance routines.

“Lung health has historically been treated as reactive care, but it plays a critical role in how we perform, recover, and feel every day,” said Eric Kau, Co-founder and Chief Executive Officer of Climatic, in the launch announcement. He argues that by actively cleansing airways, L Max provides the daily support needed for easier breathing and enhanced athletic performance.

The Science of a Deeper Breath

Climatic’s primary differentiator in a crowded wellness market is its delivery method and the science backing it. Unlike pills or powders that enter the digestive system, L Max delivers a blend of all-natural ingredients directly to the lungs. The company claims this targeted approach supports the body’s natural mucociliary clearance process—the system responsible for sweeping contaminants out of the airways.

To substantiate these claims, Climatic highlights a partnership with Mount Sinai Medical Center. Research conducted there, reportedly utilizing an in vivo model, showed that a single use of the L Max formulation improved mucus clearance by more than 50%, with the effects lasting up to eight hours. While the company states these results are being prepared for peer-reviewed publication, the initial data points to a tangible physiological effect. The research was led by a team including Dr. Dale Christensen, Climatic’s Chief Science Officer and an Adjunct Associate Professor at Duke University.

Further underscoring its commitment to scientific validation, Climatic has registered a randomized, placebo-controlled clinical trial with the U.S. National Library of Medicine. The study (NCT07102680) is designed to evaluate the lung-cleansing effects and performance benefits of L Max in healthy adult athletes compared to a placebo. This move toward rigorous clinical testing is a notable step for a product positioned in the wellness and supplement space, which often relies more on marketing than on clinical data.

A New Frontier in Wellness

Climatic is not just launching a product; it’s attempting to engineer a new market category. The global respiratory health supplements market was already valued at over USD 8 billion in 2024 and is projected to nearly double by 2033, fueled by rising pollution and a post-pandemic focus on respiratory wellness. However, this market is dominated by oral supplements like vitamins and herbal capsules.

Climatic sees an opening to change consumer behavior. "Over the past decade, we've watched wellness categories go from niche to non-negotiable almost overnight," said Allie Melnick, Co-founder and Chief Commercial Officer. "Hydration used to be an afterthought. Now nobody leaves the house without a water bottle. Lung health is at that same moment, and L Max is how you build the habit."

The company's narrative taps into a potent environmental anxiety: the World Health Organization reports that 99% of the global population breathes air that exceeds its pollution guidelines. By framing lung health as a non-negotiable daily routine, Climatic hopes to position L Max as an essential tool for modern life, not just for elite athletes but for anyone living in an urban environment.

The Athlete's Edge

While the broader public is a target, Climatic's initial push is heavily focused on the performance and athletic community. The company reports that in a five-week trial with athletes, 98% of participants reported easier breathing during workouts, average time trial performance improved by 6%, and 80% saw improvements in heart rate variability (HRV), a key metric for recovery.

To build credibility, the company has enlisted an impressive roster of experts and athletes. The product was developed in collaboration with leading pulmonary experts, including Dr. Bruce Johnson of the Mayo Clinic, a renowned researcher in human performance, and Dr. Raghu Chivukula, a pulmonary specialist at Harvard Medical School. Its athlete advisory board includes world-champion triathlete Tim O’Donnell, elite runner Sara Hall, and exercise physiologists Dr. Matt Hanson and Dr. Daniel Plews.

O’Donnell’s testimonial captures the product’s intended appeal for competitors. “With L Max, I feel like I find my rhythm a little bit quicker,” he stated. “As I’ve gotten older, warming up includes getting my lungs to expand, and normally I’m deep into a run before my breathing feels right. With L Max, I feel confident, like I can get after it right now.”

Navigating a New Market

As a novel product, L Max exists in a unique regulatory space. Climatic's website includes the standard disclaimer that its statements have not been evaluated by the Food and Drug Administration and the product is "not intended to diagnose, treat, cure or prevent any disease." This positions L Max as a dietary supplement or wellness product, avoiding the lengthy and expensive process of seeking approval as a medical device or drug.

For its core athletic audience, the company emphasizes safety and compliance. The all-natural ingredients are WADA-compliant, and the product is third-party tested and manufactured in GMP-certified facilities. This assurance is critical for competitive athletes who are subject to strict anti-doping regulations.

Initial reception is limited to testimonials curated by the company, which praise the device for reducing post-exercise coughing and improving performance. Widespread, independent user reviews have yet to surface, which is typical for a brand-new product launch. The success of L Max will ultimately depend on whether early adopters find its benefits compelling enough to justify the price—a starter set costs $95 for a one-time purchase or $55 per month on subscription—and to incorporate a new, unfamiliar routine into their daily lives. The challenge for Climatic is not just to sell a product, but to sell an entirely new habit.